12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Assessing the safety of beta-blocker therapy in cirrhosis patients with ascites: A meta-analysis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Beta-blocker therapy is effective at reducing risks of variceal bleeding. However, beta-blockers may detrimentally exacerbate the underlying haemodynamic changes in cirrhosis. A systematic review and meta-analysis was performed to evaluate impact of beta-blockers on all-cause mortality among cirrhosis patients with ascites.

          Related collections

          Author and article information

          Journal
          Liver Int.
          Liver international : official journal of the International Association for the Study of the Liver
          Wiley
          1478-3231
          1478-3223
          Jun 2019
          : 39
          : 6
          Affiliations
          [1 ] Department of Medicine, Division of Gastroenterology and Hepatology, Alameda Health System - Highland Hospital, Oakland, CA.
          Article
          10.1111/liv.14040
          30614656
          b5669feb-5f7c-431a-8040-c31e1b90b145
          History

          ascites,portal hypertension,cirrhosis,beta-blockers,all-cause mortality

          Comments

          Comment on this article